Neurocrine Biosciences
NBIX
#1397
Rank
NZ$26.23 B
Marketcap
NZ$263.12
Share price
-1.26%
Change (1 day)
19.84%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company